ArticleAlimentary pharmacology & therapeutics2021

Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity.

Won KimPubMed ↗Publisher ↗

No numbers read from the abstract.